NeuroBo Pharmaceuticals, Inc. submitted an Investigational New Drug application to the FDA for a Phase 2a clinical trial of DA-1241 for the treatment of nonalcoholic steatohepatitis.
AI Assistant
METAVIA INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.